## Description of Table 2:
This table measures the prevalance of the below among the 3 races, as a percentage of the total or of the various ages:
Any SUD - any_sud
\>=2 SUD - morethan2_sud
Alcohol - alc
Cannabis - cannabis
Amphetamine - amphe
Hallucinogen - halluc
Nicotine - nicotin
Cocaine - cocaine
Opioids - opioids
Sedatives/tranquilizers - sedate
Other drugs - others
Polysubstance - polysub
Inhalants - inhalant

### Quantities of patients with SUDs, by race
|Quantity            |Asian Americans     |NHPI                |Multi-Ethnic        |
|--------------------|--------------------|--------------------|--------------------|
|**any SUD**|**Total:341**|**Total:684**|**Total:1802**|
|**at least 2 SUDs**|**Total:91**|**Total:152**|**Total:556**|

***
### Categorised percentages of SUD patients, via race
|Substance, %        |Asian Americans     |NHPI                |Multi-Ethnic        |
|--------------------|--------------------|--------------------|--------------------|
|alc|54.5|40.2|35.2|
|cannabis|32.8|38.2|34.3|
|amphe|5.3|1.9|3.2|
|halluc|1.2|0.9|0.6|
|nicotin|8.5|2.5|11.2|
|cocaine|10.6|9.6|15.9|
|opioids|12.6|10.1|24.4|
|sedate|2.3|1.5|3.8|
|others|1.5|0.6|1.4|
|polysub|0.0|0.0|0.0|
|inhalant|2.6|3.2|2.4|

***
### Categorised percentages of all SUD patients, via race, separated into age bins
|Race, qty           |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|AA|0.0|12.9|54.8|23.5|8.8|
|NHPI|0.6|25.7|36.8|24.3|12.4|
|MR|0.6|6.2|38.7|32.8|21.8|

### Categorised percentages of Asian American patients separated into age bins
|Substance, %        |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|alc|0.0|11.3|54.8|21.0|12.9|
|cannabis|0.0|26.8|54.5|17.0|1.8|
|amphe|0.0|5.6|72.2|22.2|0.0|
|halluc|0.0|25.0|75.0|0.0|0.0|
|nicotin|0.0|6.9|55.2|24.1|13.8|
|cocaine|0.0|0.0|47.2|36.1|16.7|
|opioids|0.0|2.3|74.4|20.9|2.3|
|sedate|0.0|12.5|75.0|12.5|0.0|
|others|0.0|20.0|80.0|0.0|0.0|
|polysub|0|0|0|0|0|
|inhalant|0.0|22.2|66.7|11.1|0.0|

***
### Categorised percentages of Native Hawaiian patients separated into age bins
|Substance, %        |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|alc|0.4|16.4|37.8|27.6|17.8|
|cannabis|0.4|47.9|36.8|11.5|3.1|
|amphe|0.0|15.4|38.5|15.4|30.8|
|halluc|0.0|50.0|0.0|16.7|33.3|
|nicotin|0.0|17.6|17.6|23.5|41.2|
|cocaine|0.0|9.1|37.9|40.9|12.1|
|opioids|1.4|8.7|26.1|36.2|27.5|
|sedate|0.0|0.0|30.0|30.0|40.0|
|others|0.0|0.0|75.0|25.0|0.0|
|polysub|0|0|0|0|0|
|inhalant|0.0|13.6|72.7|13.6|0.0|

***
### Categorised percentages of Multi-ethnic patients separated into age bins
|Substance, %        |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|alc|0.0|4.4|42.3|30.6|22.7|
|cannabis|1.0|14.7|57.1|21.0|6.1|
|amphe|0.0|3.4|75.9|12.1|8.6|
|halluc|0.0|0.0|80.0|0.0|20.0|
|nicotin|0.0|2.5|36.1|36.6|24.8|
|cocaine|0.0|0.3|28.3|46.5|24.8|
|opioids|0.0|0.2|15.5|46.1|38.2|
|sedate|0.0|2.9|23.5|47.1|26.5|
|others|0.0|8.0|28.0|48.0|16.0|
|polysub|0|0|0|0|0|
|inhalant|0.0|11.6|48.8|30.2|9.3|

***